Skip to content

Thromboelastometry-guided Treatment Protocol Versus Standard Care of Major Haemorrhage in Obstetric Patients

Thromboelastometry-guided Treatment Protocol Versus Standard Care of Major Haemorrhage in Obstetric Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02461251
Acronym
ROTEM-PPH
Enrollment
59
Registered
2015-06-03
Start date
2016-01-31
Completion date
2020-01-31
Last updated
2020-01-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemorrhage, Obstetric Labor Complications

Keywords

Thromboelastometry, Obstetric Hemorrhage, Blood Component Transfusion

Brief summary

This is a prospective, randomized and controlled study to find out if a rotational thromboelastometry(ROTEM) guided treatment protocol reduces the need for blood transfusions in major obstetric haemorrhage compared to standard care of clinical decision making, conventional coagulation tests and massive transfusion protocol. Secondary aim is to find out if ROTEM can predict the incidence of thromboembolic events in this patient group.

Detailed description

A comparison of two different treatment protocols is made in patients suffering major obstetric haemorrhage: those who after a normal delivery are bleeding more than 1000 ml and are in need of surgical intervention to control the bleeding and those in cesarean section with ongoing bleeding of more than 1000 ml. Patients are randomized in to two groups: the control group(n=30) will be treated according to a protocol based on clinical decision making, standard coagulation tests and massive transfusion packages of blood products(1:1:1), if needed. This is referred as 'Standard care' in this hospital. The intervention group(n=30) will be treated according to a rotational thromboelastometry guided protocol, and massive transfusion packages, if needed. The study is powered to detect a reduction of one unit in red blood cell transfusion. Blood product, fibrinogen concentrate, prothrombin complex concentrate usage and total amount of blood loss will be compared, and the number of transfusion related side effects and thromboembolic events 30 days after the bleeding will be recorded.

Interventions

DEVICERotational Thromboelastometry (ROTEM)

A Point-of-care blood coagulation test tool is used to guide the treatment of major obstetric bleeding.

Sponsors

Tampere University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age over 18 * Severe post-partum haemorrhage ie. active bleeding of more than 1000ml within 24 hours after vaginal delivery or cesarean section * Informed consent (after randomization)

Exclusion criteria

* Known hemophilia or von Willebrand's disease * Unacceptance of allogeneic blood products(Jehovah's witnesses)

Design outcomes

Primary

MeasureTime frame
Reduction in blood transfusions24 h

Secondary

MeasureTime frame
Reduction of transfusion related side-effects30 days
Number of thromboembolic events30 days

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026